EUVIMEDEUVIMED entdecken
Crossref

A biomimetic nanodrug for enhanced chemotherapy of pancreatic tumors

Fu Zhang, Qida Hu, Bowen Li, Yong Huang, Meng Wang, Shiyi Shao, Honglin Tang, Zhuo Yao, Yuan Ping, Tingbo Liang

Journal of Controlled Release · 2023-02 · 354 · 835-850

DOI: 10.1016/j.jconrel.2023.01.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2023-02. Verfasst von Fu Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou 310…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Nanoparticles. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) remains to be one of the highest malignant tumors due to its poor chemotherapeutic efficacy and multidrug resistance. A major reason for the failure in chemotherapy is poor drug accumulation into PDAC tumor tissues due to the overexpressed extracellular matrix (ECM) stroma, which forms a major obstacle limiting the deep tissue penetration of chemotherapeutics. Herein, we report a tumor microenvironment (TME)-responsive nanodrug, based on PDAC cell membrane-coated gold nanocages (AuNCs), to co-deliver the chemotherapeutics (GEM) and nitrogen oxide (NO) donor (L-Arg) to enhance drug accumulation and reduce chemoresistance. The high glutathione (GSH) level can trigger the cleavage of the disulfide bond on nanodrug to release GEM. Moreover, the elevated ROS level could activate L-Arg to generate NO, which synergistically facilitate GEM to penetrate into deep tissues by means of vasodilation and normalization of blood vessels in the PDAC tumor tissue. In addition, AuNCs not only serve as a photothermal agent for chemotherapy, but also generate photoacoustic signals to monitor drug accumulation and distribution. As expected, the strategy demonstrates to be remarkable in treating different xenograft mice models, especially in orthotopic and patient-derived xenograft (PDX) models. The current study defines a useful therapeutic tool for treating PDAC tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalNanoparticlesHumansMiceAnimalsGemcitabineDeoxycytidineBiomimeticsCell Line, TumorXenograft Model Antitumor AssaysTumor Microenvironment

Stichwörter der Autor:innen

Gas therapyGemcitabine chemotherapyGold nanocagesPancreatic cancerPhotoacoustic tomography

Substanzen

GemcitabineDeoxycytidine

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou 310003, China; College of Pharmaceutical Sciences, Zhejiang University, H…
  • Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou 310003, China.
  • College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China; Department of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive, Singapore, 117585, Singapore.…
  • College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
  • College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. Electronic address: pingy@zju.edu.cn.
  • Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou 310003, China; Zhejiang Provincial Key Laboratory of Pancreatic Disease,…

Zitieren

APA

Zhang, F., Hu, Q., Li, B., Huang, Y., Wang, M., Shao, S., Tang, H., Yao, Z., Ping, Y., & Liang, T. (2023). A biomimetic nanodrug for enhanced chemotherapy of pancreatic tumors. Journal of Controlled Release, 354, 835-850. https://doi.org/10.1016/j.jconrel.2023.01.007

Vancouver

Zhang F, Hu Q, Li B, Huang Y, Wang M, Shao S, et al. A biomimetic nanodrug for enhanced chemotherapy of pancreatic tumors. Journal of Controlled Release. 2023;354:835-850. doi:10.1016/j.jconrel.2023.01.007

BibTeX
@article{Zhang2023,
  author = {Zhang, Fu and Hu, Qida and Li, Bowen and Huang, Yong and Wang, Meng and Shao, Shiyi and Tang, Honglin and Yao, Zhuo and Ping, Yuan and Liang, Tingbo},
  title = {A biomimetic nanodrug for enhanced chemotherapy of pancreatic tumors},
  journal = {Journal of Controlled Release},
  year = {2023},
  volume = {354},
  pages = {835--850},
  doi = {10.1016/j.jconrel.2023.01.007}
}
Kostenlos starten →